Management of ST-Elevation Myocardial Infarction in High-Risk Settings
Mohamed A Omer1,2, Jose E Exaire1,2, Jacob C Jentzer3
1Cardiovascular Services, Mayo Clinic Health System, La Crosse, Wisconsin.
Insights
ST-segment elevation myocardial infarction (STEMI) is a major cause of death. This review covers state-of-the-art treatments for high-risk STEMI patients, including cardiogenic shock and mechanical complications.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- ST-segment elevation myocardial infarction (STEMI) remains a leading cause of death globally.
- Despite advances, high-risk STEMI patients present diagnostic and therapeutic challenges.
Purpose of the Study:
- To review the current state-of-the-art treatment strategies for STEMI.
- To focus on complex STEMI presentations including cardiogenic shock, cardiac arrest, and mechanical complications.
Main Methods:
- Literature review of current treatment guidelines and landmark trials.
- Analysis of diagnostic and therapeutic approaches for specific high-risk STEMI subgroups.
Main Results:
- Primary percutaneous intervention and modern antithrombotic therapy have improved STEMI prognosis.
- Specific challenges in managing cardiogenic shock, cardiac arrest, and mechanical complications are discussed.
Conclusions:
- Optimal management of STEMI requires addressing complex patient subsets.
- Continued research and guideline adherence are crucial for improving outcomes in STEMI.
Abstract:
Despite the widespread adoption of primary percutaneous intervention and modern antithrombotic therapy, ST-segment elevation myocardial infarction (STEMI) remains the leading cause of death in the United States and remains one of the most important causes of morbidity and mortality worldwide. Certain high-risk patients present a challenge for diagnosis and treatment. The widespread adoption of primary percutaneous intervention in addition to modern antithrombotic therapy has resulted in substantial improvement in the short- and long-term prognosis following STEMI. In this review, we aim to provide a brief analysis of the state-of-the-art treatment for patients presenting with STEMI, focusing on cardiogenic shock, current treatment and controversies, cardiac arrest, and diagnosis and treatment of mechanical complications, as well as multivessel and left main-related STEMI.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Acute Coronary Syndrome I: Introduction
01:14Myocarditis III: Medical Management
01:20Angina V: Nursing Management
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations